<DOC>
	<DOC>NCT02431741</DOC>
	<brief_summary>This is a prospective, open, non-controlled clinical investigation to evaluate the performance and safety of using Mepilex Transfer Ag on a malignant wound. Approximately ten to fifteen (10-15) subjects from one to three centers in Europe, presenting with a malignant (fungating) wound will be enrolled into the study. Eligible subjects will have one malignant (fungating) wound selected as a "study site". Subjects will be followed for a one-week observation period with their existing product followed by a 4-week investigation period using Mepilex Transfer Ag.</brief_summary>
	<brief_title>A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment Both genders with an age â‰¥ 18 years at randomization Subjects with a suspected survival time of &gt; 3 months Signed informed consent Any known or suspected systemic infection Use of metronidazole is not allowed during the investigation period Any known sensitivity to silver or other components/products used in this study. Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders. Participation in another investigational study while participating in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment</keyword>
</DOC>